Bir v. Pfizer, Inc.

510 F. App'x 29
CourtCourt of Appeals for the Second Circuit
DecidedJanuary 31, 2013
Docket12-0648-cv
StatusUnpublished
Cited by9 cases

This text of 510 F. App'x 29 (Bir v. Pfizer, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bir v. Pfizer, Inc., 510 F. App'x 29 (2d Cir. 2013).

Opinion

SUMMARY ORDER

Plaintiff-Appellant Nicole A. Bir appeals from an award of summary judgment in favor of Pfizer, Inc. (“Pfizer”), in whose employ she worked from 1997 until 2006 as a sales representative. Her action asserts claims under Title VII of the Civil Rights Act of 1964 (“Title VII”), 42 U.S.C. §§ 2000e-2000el7; the New York State Human Rights Law (“NYSHRL”), N.Y. Exec. Law §§ 290-801; the Equal Pay Act, 29 U.S.C. § 206(d); New York Labor Law § 194; and New York common law. Because plaintiff withdrew her common law claims during the district court proceeding and fails in her appellate brief to address her Equal Pay Act, New York Labor Law § 194, and constructive discharge claims, we consider these claims abandoned for the purpose of this appeal. Plaintiffs remaining claims, brought under Title VII and the NYSHRL, rest on her allegations that during her employment at Pfizer, she was subject to unlawful discriminatory treatment based on her gender, a hostile work environment, and unlawful retaliation for her complaints about the foregoing. 1 We assume the parties’ familiarity with the underlying facts, the procedural history, and the issues on appeal, to which we refer only as necessary to explain our decision.

A. Adverse Action Claims

To establish a prima facie case of intentional discrimination under Title VII or the NYSHRL, a plaintiff must show that “(1) [s]he is a member of a protected class; (2) [s] he was qualified for the position [s]he held; (3) [s]he suffered an adverse employment action; and (4) the adverse action took place under circumstances giving rise to an inference of discrimination.” Reynolds v. Barrett, 685 F.3d 193, 202 (2d Cir. 2012) (internal quotation marks and alteration omitted). Under the familiar McDonnell Douglas burden-shifting framework, once a plaintiff establishes a prima facie case, the burden shifts to the employer to provide a legitimate non-discriminatory reason for the employment action at issue. See Reeves v. Sanderson Plumbing Prods., Inc., 530 U.S. 133, 142, 120 S.Ct. 2097, 147 L.Ed.2d 105 (2000). If the defendant makes this showing, the burden then shifts back to the plaintiff to show that the defendant’s proffered explanation is pretex- *31 tual. Ruiz v. County of Rockland, 609 F.3d 486, 492 (2d Cir.2010).

In attempting to demonstrate Pfizer’s alleged discriminatory animus, plaintiff points to the conduct of only one Pfizer employee, Scott Welch, who was plaintiffs supervisor from 1997 through 1999 and then again from 2005 through 2006. She explains that along with his hostile behavior in the workplace (described further below), Welch told her in September 2005 that “when women get married and have children, their priorities change and they don’t work as hard.” J.A. 875. This statement, she argues, presents “direct” evidence of Welch’s discriminatory animus towards women (or married women in particular), 2 and thus supports an inference of discrimination on the part of Pfizer. She fails, however, to offer evidence sufficient to establish that she was subject to any adverse employment actions resulting from Welch’s conduct. Any of the adverse actions that plaintiffs evidence suggests she did suffer are too disconnected from Welch to plausibly be tainted by his alleged animus.

In support of her adverse action claims, plaintiff points to two promotions she sought in 2006 but did not receive: first, for a position as Cleveland Assistant Regional Manager, and second, for a position as a Senior Specialty Sales Representative. 3 Even assuming plaintiff did state a prima facie case regarding either of these asserted adverse actions, she has failed as a matter of law to demonstrate that any of the reasons provided by defendant for these failures to promote is pretextual.

With regard to the Cleveland Assistant Regional Manager position, 4 plaintiff alleges that she applied for and was interviewed for this position, but she does not provide any evidence about who made the decision not to offer her the position or who ultimately was offered the job. She alleges that “she was informed that she did not get this position because she needed the support of all local managers which would have included, among others, Scott Welch,” implying that she did not have Welch’s support and was denied the position, in part, for that reason. J.A. 838. But no record evidence suggests that Welch was at all involved in the decision to deny her this position.

Plaintiffs claims based on Pfizer’s failure to offer her a Specialty Sales Representative position also fail. Although Pfizer named a male sales representative to this position, plaintiff has not provided any evidence contradicting Welch’s deposition testimony that this representative had a consistently higher sales ranking than plaintiff, and that Welch — once again, the *32 only Pfizer employee about whom plaintiff has proffered any evidence of discriminatory animus — played no direct part in the decision not to promote plaintiff to this position.

In light of plaintiff’s inability to establish any connection between Welch and either of these failures to promote, and plaintiffs below-average work performance, the only reasonable conclusion to be drawn from the evidence is that plaintiff was denied these promotions because of her inferior sales record. There is therefore nothing in the record that “reasonably supports a finding of prohibited discrimination,” James v. N.Y. Racing Ass’n, 233 F.3d 149, 154 (2d Cir.2000).

Plaintiff also complains that employees were evaluated based on both “sales numbers” (as measured relative to quotas set by corporate decisionmakers) and “sales behavior” (as measured through observations made by supervisors such as Welch). This evidence suggests that during the years Welch supervised her, plaintiff was evaluated in part based on Welch’s reviews. But plaintiff does not dispute that her sales rankings (ie., her sales performance relative to her quotas as measured against the same figure for other sales representatives) were consistently below average. Moreover, she cannot overcome documentary evidence demonstrating that her supervisors between 1999 and 2005— who did not include Welch — gave her negative reviews. See, e.g., id. at 152 (holding that plaintiff’s claim failed as a matter of law despite his prima facie showing, because “overwhelming” evidence supported defendant’s proffered explanation).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Horal v. IHR, Inc.
Tenth Circuit, 2022
Panagopoulos v. New York State Department of Transportation
172 F. Supp. 3d 597 (N.D. New York, 2016)
DeMoss v. Norwalk Board of Ed.
21 F. Supp. 3d 154 (D. Connecticut, 2014)
Greene v. Brentwood Union Free School District
966 F. Supp. 2d 131 (E.D. New York, 2013)
Seale v. Madison Cnty
929 F. Supp. 2d 51 (N.D. New York, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
510 F. App'x 29, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bir-v-pfizer-inc-ca2-2013.